Q4 2021 Xenon Pharmaceuticals Inc Earnings Call Transcript

Mar 01, 2022 / 09:30PM GMT
Operator

Thank you for standing by, and welcome to Xenon Pharmaceuticals 2021 Year-end Financial Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your host, Sherry Aulin, Chief Financial Officer of Xenon Pharmaceuticals. Please go ahead.

Sherry Aulin - Xenon Pharmaceuticals Inc. - CFO

Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon's year-end 2021 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer.

Please be advised that during this call, we will make a number of statements that are forward-looking, including statements regarding the research and clinical development plans and time lines and results of operations, the timing of and results from clinical trials and preclinical development activities of our proprietary and partnered product

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot